Correlation Between Beingmate Baby and Maccura Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beingmate Baby and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beingmate Baby and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beingmate Baby Child and Maccura Biotechnology Co, you can compare the effects of market volatilities on Beingmate Baby and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beingmate Baby with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beingmate Baby and Maccura Biotechnology.

Diversification Opportunities for Beingmate Baby and Maccura Biotechnology

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Beingmate and Maccura is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Beingmate Baby Child and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Beingmate Baby is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beingmate Baby Child are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Beingmate Baby i.e., Beingmate Baby and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Beingmate Baby and Maccura Biotechnology

Assuming the 90 days trading horizon Beingmate Baby Child is expected to generate 1.31 times more return on investment than Maccura Biotechnology. However, Beingmate Baby is 1.31 times more volatile than Maccura Biotechnology Co. It trades about 0.0 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about -0.03 per unit of risk. If you would invest  491.00  in Beingmate Baby Child on November 1, 2024 and sell it today you would lose (84.00) from holding Beingmate Baby Child or give up 17.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Beingmate Baby Child  vs.  Maccura Biotechnology Co

 Performance 
       Timeline  
Beingmate Baby Child 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Beingmate Baby Child has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Maccura Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Beingmate Baby and Maccura Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beingmate Baby and Maccura Biotechnology

The main advantage of trading using opposite Beingmate Baby and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beingmate Baby position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.
The idea behind Beingmate Baby Child and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios